Assessment of the Effectiveness of Muscle Activating Training With the Use of EMG Biofeedback in Patients With Neuromuscular Diseases

EGZOTech

Status: Unknown

Conditions: Neuromuscular Diseases

Treatments: Device: Stella BIO

Study type: Observational

Funder types: Industry

Identifiers

NCT05122273

Orthos Trial

Details and patient eligibility

About

The aim of this study is to assess the impact of individually planned therapeutic procedures, using, among others, the concept of EMG biofeedback, to improve the general functional state, selected motor activities, stimulation and strength of specific muscle syndromes as well as postural parameters in children, adolescents and adults with neuromuscular diseases.

Enrollment: 8 estimated patients

Sex: All

Ages: 3 to 25 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• confirmed genetic Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD), limb-girdle dystrophy, spinal muscular atrophy (SMA), myopathy or neuropathy
• continued/uninterrupted rehabilitation process for 3 months
• patient's condition allowing full understanding of commands

Exclusion criteria

• patients using a respirator
• painful complaints
• after injuries and fractures in the last 6 months
• significant weakening of muscle strength, preventing movements and activation of selected muscle groups, visible in the EMG examination
• cognitive impairment-lack of or poor cooperation between the patient and the therapist,

Trial design

8 participants in 1 patient group

Children and adults with confirmed neuromuscular disease

Description:

Children and adults with confirmed genetic Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD), limb-girdle dystrophy, spinal muscular atrophy (SMA), myopathy or neuropathy.

Treatment:

Device: Stella BIO